Quantitative Health Risk Analysis Methods : Modeling the Human Health Impacts of Antibiotics Used in Food Animals (International Series in Operations Research and Management Science) / L. A. Cox, Jr.

Quantitative Health Risk Analysis Methods : Modeling the Human Health Impacts of Antibiotics Used in Food Animals (International Series in Operations Research and Management Science) 〈Vol. 82〉

個数：

Quantitative Health Risk Analysis Methods : Modeling the Human Health Impacts of Antibiotics Used in Food Animals (International Series in Operations Research and Management Science) 〈Vol. 82〉

L. A. Cox, Jr.

ウェブストア価格 ¥22,919（本体¥20,836）
Springer（2005/12発売）
外貨定価 US$ 109.99
ポイント 208pt

提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
【重要ご説明事項】
1. 納期遅延や、ご入手不能となる場合が若干ございます。
2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
3. 美品のご指定は承りかねます。

●3Dセキュア導入とクレジットカードによるお支払いについて

【入荷遅延について】
世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。

◆画像の表紙や帯等は実物とは異なる場合があります。

◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
また、洋書販売価格は、ご注文確定時点での日本円価格となります。
ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。

製本 Hardcover:ハードカバー版／ページ数 358 p.／サイズ 33 illus.
言語 ENG
商品コード 9780387259093

基本説明

Provides and illustrate methods for quantitative risk assessment and for comparing alternative risk management actions, given realistic limitations on scientific knowledge and available data.

Full Description

This book grew out of an effort to salvage a potentially useful idea for greatly simplifying traditional quantitative risk assessments of the human health consequences of using antibiotics in food animals. In 2001, the United States FDA's Center for Veterinary Medicine (CVM) (FDA-CVM, 2001) published a risk assessment model for potential adverse human health consequences of using a certain class of antibiotics, fluoroquinolones, to treat flocks of chickens with fatal respiratory disease caused by infectious bacteria. CVM's concern was that fluoroquinolones are also used in human medicine, raising the possibility that fluoroquinolone-resistant strains of bacteria selected by use of fluoroquinolones in chickens might infect humans and then prove resistant to treatment with human medicines in the same class of antibiotics, such as ciprofloxacin. As a foundation for its risk assessment model, CVM proposed a dramatically simple approach that skipped many of the steps in traditional risk assessment. The basic idea was to assume that human health risks were directly proportional to some suitably defined exposure metric. In symbols: Risk = K x Exposure, where "Exposure" would be defined in terms of a metric such as total production of chicken contaminated with fluoroquinolone-resistant bacteria that might cause human illnesses, and "Risk" would describe the expected number of cases per year of human illness due to fluoroquinolone-resistant bacterial infections caused by chicken and treated with fluoroquinolones.

Qualitative and Quantitative Risk Analysis.- Risk Analysis: Goals and Methods.- Hazard Identification.- Exposure Assessment.- Dose-Response Modeling and Risk Characterization.- Human Health Risks from Virginiamycin: A Case Study.- Dynamic Modeling and Uncertainty Analysis.- Potential Human Health Benefits of Animal Antibiotics.